Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This single-institution cross-sectional non-inferiority validation study evaluates alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytology staining techniques, local HPV tests.
Cervical cytology practices are different across the world. While the Pap test became the cornerstone of the highly-effective cervical cancer screening in the countries that initially implemented population-based programs in the 60s and the 70s, alternative staining techniques were implemented in the Soviet Union. The tradition to apply other staining techniques than conventional Pap test remained unchanged in the national screening program implemented in the 2010s in Russia. As a new alternative option HPV testing showed effectiveness in screening women older than 30. The acceptable sensitivity and specificity of a screening test are crucial in population-based screening, that is why validation against "the gold standard" should be the first step in the process of program implementation. The objective of this study is to evaluate alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytology staining techniques, local HPV tests in the population of 25-65 yo women without prior history of malignancy referred to colposcopy enriched with a population sample of women from several primary healthcare facilities referred to a primary screening test.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High risk group | Women in the age group between 25 and 65 years old without prior history of malignancy referred to colposcopy |
| |
| Population sample | A population sample of women in the age group between 25 and 65 years old from several primary healthcare facilities to primary cervical screening |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Papanicolaou cytological test | Diagnostic Test | Cervical smear stained using conventional Papanicolaou technique. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity | Cervical screening tests sensitivity | 24 months |
| Specificity | Cervical screening tests specificity | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| HPV prevalence by type | HPV prevalence by type based on genotyping in the population sample | 24 months |
| Cervical dysplasia prevalence | Prevalence of cervical dysplasia in the population sample |
| Measure | Description | Time Frame |
|---|---|---|
| Safety of cervical smear | Adverse events after cervical smear | 24 months |
| Safety of colposcopy and biopsy | Adverse events after colposcopy and biopsy |
Inclusion Criteria:
Age between 25 and 65 years old Referral to colposcopy or to a primary screening test Signed informed consent
Exclusion Criteria:
Prior history of malignancy or cervical dysplasia Prior history of cervical dysplasia
Gender identity
25-65 year-old women without prior history of malignancy referred to colposcopy enriched with a population sample of women from several primary healthcare facilities.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| N.N. Petrov National Medical Research Center of Oncology | Recruiting | Saint Petersburg | 197758 | Russia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| D002578 | Uterine Cervical Dysplasia |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
| ID | Term |
|---|---|
| D003127 | Colposcopy |
| ID | Term |
|---|---|
| D003944 | Diagnostic Techniques, Obstetrical and Gynecological |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D004724 | Endoscopy |
Not provided
Not provided
Not provided
Not provided
Not provided
Cytology and biopsy samples
| Local cytological test (H&E stain) | Diagnostic Test | Cervical smear stained using conventional hematoxylin and eosin staining techniques |
|
| Validated HPV DNA Test | Diagnostic Test | Digene HC2 HPV DNA Test |
|
| Local HPV test | Diagnostic Test | RealBest DNA HPV HR genotype (differential detection of human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 DNA) |
|
| Colposcopy | Diagnostic Test | Women with positive cytology results are referred to colposcopy and biopsy |
|
| 24 months |
| 24 months |
| D009369 |
| Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D011230 | Precancerous Conditions |
| D003949 | Diagnostic Techniques, Surgical |
| D019060 | Minimally Invasive Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D013513 | Obstetric Surgical Procedures |
| D013509 | Gynecologic Surgical Procedures |
| D013519 | Urogenital Surgical Procedures |